Last reviewed · How we verify

NCT05139953

Impact of COVID-19 Infection During Pregnancy

Completed Last updated 1 December 2021
What this trial tests

trial testing No intervention in Covid-19 in Pregnancy in 65 participants. Completed in 31 July 2021.

Timeline
1 May 2020
Primary endpoint
31 July 2021
31 July 2021

Quick facts

Lead sponsorMenoufia University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment65
Start date1 May 2020
Primary completion31 July 2021
Estimated completion31 July 2021
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Menoufia University

Who can join

Adults 18 to 45, female only, with Covid-19 in Pregnancy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To asses impact of the COVID-19 infection during Pregnancy on maternal and fetal outcome in relation to gestational age.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

Other Menoufia University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05139953.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing